JNBA Financial Advisors »

Theravance Biopharma shares owned by JNBA Financial Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by JNBA Financial Advisors from 13F filings

Historical chart of JNBA Financial Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by JNBA Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by JNBA Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $12 1 12.00
2023-09-30 $9 1 9.00

More positions owned by JNBA Financial Advisors

Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Vanguard Index Fds Growth Etf (VUG)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
AFLAC Incorporated (AFL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for JNBA Financial Advisors

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
Vanguard Group
Newtyn Management
Park West Asset Management
D. E. Shaw & Co
Bank of America Corporation
Jacobs Levy Equity Management
Jane Street
Charles Schwab Investment Management
Wellington Management Company
Goldman Sachs Group
Chescapmanager
SG Americas Securities
Highbridge Capital Management

View all funds holding Theravance Biopharma